Characteristics associated with the initiation of radiation therapy after breast-conserving surgery among African American and white women diagnosed with early-stage breast cancer in Maryland, 2000-2006

Annals of Epidemiology

Volumn 22, Issue 1, 2012, Pages 28-36

  Royak Schaler, Renee ^a   Pelser, Colleen ^a,c   Langenberg, Patricia ^a   Hayes, Jennifer ^b   Gardner, Lisa ^a   Nesbitt, Kim ^a   Citron, Wendla ^a   Drogula, Cynthia L ^a   Dwyer, Diane ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast Cancer; Breast Conserving Surgery; Health Disparities; Radiation Therapy

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SIZE; EARLY CANCER; FEMALE; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; PARTIAL MASTECTOMY; PATIENT CARE; PRIORITY JOURNAL; SOCIOECONOMICS; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MARYLAND; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; REGISTRIES; REGRESSION ANALYSIS;

EID: 83055180689     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2011.10.001     Document Type: Article

References (64)

1. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
2. Fisher B., Bryant J., Dignam J.J., Wickerham D.L., Mamounas E.P., Fisher E.R., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002, 20:4141-4149.
3. Fisher B., Land S., Mamounas E., Dignam J., Fisher E.R., Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001, 28:400-418.
4. Julien J.P., Bijker N., Fentiman I.S., Peterse J.L., Delledonne V., Rouanet P., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853-EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000, 355:528-533.
5. Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 2003, 362:95-102.
6. White J., Morrow M., Moughan J., Owen J., Pajak T., DesHarnais S., et al. Compliance with breast conservation standards for patients with early stage breast carcinoma. Cancer 2003, 97:893-904.
7. Treatment of early-stage breast cancer. JAMA 1991, 265:391-395. National Institute of Health Consensus Conference.
8. Cathcart C., Dunican A., Halpern J. Patterns of delivery of radiation therapy in an inner-city population of head and neck cancer patients: an analysis of compliance and end results. J Med 1997, 28:275-284.
9. Berger D., Braverman A., Sohn C., Morrow M. Patient compliance with aggressive multimodal therapy in locally advanced breast cancer. Cancer 1988, 61:1453-1456.
10. Kiebert G.M., de Haes J.C., van de Velde C.J. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: A review. J Clin Oncol 1991, 9:1059-1070.
11. Pusic A., Thompson T.A., Kerrigan C.L., Sargeant R., Slezak S., Chang B.W., et al. Surgical options for the early-stage breast cancer: factors associated with patient choice and postoperative quality of life. Plast Reconstr Surg 1999, 104:1325-1333.
12. Lazovich D., Solomon C.C., Thomas D.B., Moe R.E., White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health consensus development conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999, 86:628-637.
13. Nattinger A.B., Hoffmann R.G., Shapiro R., Gottlieb M.S., Goodwin J.S. The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med 1996, 335:1035-1040.
14. Nattinger A.B., Hoffman R.G., Howell-Pelz A., Goodwin J.S. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA 1998, 279:762-766.
15. Nattinger A., Hoffmann R., Kneusel R., Schapira M. Relation between appropriateness of primary therapy for early stage breast carcinoma and increased use of breast-conservation surgery. Lancet 2000, 356:1148-1153.
16. Buchholz T., Theriault R., Niland J., Hughes M.E., Ottesen R., Edge S.B., et al. The use of radiation as a component of breast conservation therapy in national comprehensive cancer network centers. J Clin Oncol 2006, 24:361-369.
17. Schootman M., Aft R. Rural-urban differences in radiation therapy for ductal carcinoma in-situ of the breast. Breast Cancer Res Treat 2001, 68:117-125.
18. SEER Cancer Statistics Review, 1973-1997 2000, National Cancer Institute, Bethesda, MD. L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, L. Clegg (Eds.).
19. Marbella A.M., Layde P.M. Racial trends in age-specific breast cancer mortality rates in US women. Am J Publ Health 2001, 91:118-121.
20. Maryland Cancer Registry, Maryland Division of Health Statistics, DHMH, 2003. Available at: Accessed October 12, 2011. http://fha.maryland.gov/pdf/cancer/CRF_Annual_Cancer_Report_2003.pdf.
21. Royak-Schaler R., Rose D.P. Mammography screening and breast cancer biology in African American women-A review. Cancer Detect Prev 2002, 26:180-191.
22. Joslyn S.A., West M.M. Racial differences in breast carcinoma survival. Cancer 2000, 88:114-123.
23. Krieger N., Quesenberry C., Peng T., Horn-Ross P., Stewart S., Brown S., et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, black, Hispanic, and white residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 1999, 10:525-537.
24. Kelsey J.L., Horn-Ross P.L. Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993, 15:7-16.
25. Krieger N. Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences in breast cancer incidence. Breast Cancer Res Treat 1989, 13:205-223.
26. Mandelblatt J., Andrews H., Kerner J., Zauber A., Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: The impact of age, race, social class, and hospital type. Am J Public Health 1991, 81:646-649.
27. Ward E., Jemal A., Cokkinides V., Singh G., Cardinez C., Ghafoor A., Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004, 54:78-93.
28. Cancer facts and figures for African Americans 2003-2004 2003, American Cancer Society, American Cancer Society, Atlanta, GA.
29. Albain K.S., Unger J.M., Hutchins L.F., Rivkin S.E., Martino S., Livingston R.B., et al. Outcome of African Americans on Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials. Breast Cancer Res Treat 2003, 82(suppl 1):S2. Abstract 21.
30. Hershman D., McBride R., Jacobson J., Lamerato L., Roberts K., Grann V.R., et al. Racial disparities in treatment and survival among women with early stage breast cancer. J Clin Oncol 2005, 23:6639-6646.
31. Williams D.R. Racial/ethnic variations in women's health: The social embeddedness of health. Am J Public Health 2002, 92:588-597.
32. Powell-Griner E., Bolen J., Bland S. Health care coverage and use of preventive services among the near elderly in the U.S. Am J Public Health 1999, 89:882-886.
33. Dignam J.J., Redmond C.K., Fisher B., Costantino J.P., Edwards B.K. Prognosis among African-American women and white women with lymph node negative breast carcinoma findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer 1997, 80:80-90.
34. Moran M.S., Yang Q., Harris L.N., Jones B., Tucker D., Haffty B.G. Long term outcomes and clinical-pathologic differences between African American and caucasian patients treated with breast conservation therapy for early stage breast cancer. Cancer 2008, 113:2565-2574.
35. Roetzheim R.G., Gonzalez E.C., Ferrante J.M., Pal N., Van Durme D.J., Krischer J.P. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 2000, 89:2202-2213.
36. Salganicoff A., Wyn R. Access to care for low-income women: The impact of Medicaid. J Health Care Poor Underserved 1999, 10:453-467.
37. Schoen C., DesRoches C. Uninsured and unstably insured: The importance of continuous insurance coverage. Health Serv Res 2000, 35:187-206.
38. U.S. Census Bureau, Table HI-1: Health Insurance Coverage Status and Type of Coverage by Sex, Race and Hispanic Origin: 1987-1999 taken from Accessed October 12, 2011. http://www.census.gov.
39. U.S. Census Bureau, Table HI-2: Health Insurance Coverage Status and Type of Coverage - All People by Age and Sex: 1987 to 1999 taken from Accessed October 12, 2011. http://www.census.gov.
40. Health, United States, 1998, Socioeconomic Status and Health Chartbook 1998, U.S. Department of Health and Human Services, U.S. DHHS, Washington, DC, (DHHS Publication No. PHS 98-1232-1).
41. Weissman J.S., Stern R., Fielding S.L., Epstein A.M. Delayed access to health care: Risk factors, reasons, and consequences. Ann Intern Med 1991, 114:325-331.
42. Wyn R., Solls B., Ojeda V., Pourat N. Falling through the cracks: Health insurance coverage of low-income women. Kaiser Family Foundation February 2001.
43. Weissman J.S., Gastonis C., Epstein A.M. Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland. JAMA 1992, 268:2388-2394.
44. Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Area Socioeconomic Variations in US Cancer Incidence, Mortality, Stage, Treatment, and Survival 1975-1999 2003, National Cancer Institute, Bethesda, MD, NCI Cancer Surveillance Monograph Series, Number 4. NIH Publication No. 03-5417.
45. Smith G.L., Shih Y.-C.T., Xu Y., Giordano S.H., Smith B.D., Perkins G.H., et al. Racial disparities in the use of radiotherapy after breast-conserving surgery. Cancer 2010, 116:734-741.
46. Smith B.D., Gross C.P., Smith G.L., Galusha D.H., Bekelman J.E., Haffty B.G. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006, 98:681-690.
47. Punglia R.S., Kuntz K.M., Lee J.H., Recht A. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: A decision analysis. J Clin Oncol 2003, 21:2260-2267.
48. Winzer K.J., Sauer R., Sauerbrei W., Schneller E., Jaeger W., Braun M., et al. Radiation therapy after breast-conserving surgery; First results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 2004, 40:998-1005. German Breast Cancer Study Group.
49. Li B.D., Brown W.A., Ampil F.L., Burton G.V., Yu H., McDonald J.C. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann Surg 2000, 231:883-889.
50. Du X.L., Gor B.J. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis 2007, 17:122-128.
51. Sharma C., Harris L., Yang Q., Haffty B.G., Moran M.S. Does compliance with radiation therapy differ in African American patients with early stage breast cancer?. Breast J 2010, 16:193-196.
52. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159:702-706.
53. Dragun A., Huang B., Tucker T.B., Spanos J.W. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: Impact on overall survival. Cancer 2011, 117:2590-2598.
54. Gold H.T., Do H.T., Dick A.W. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 2008, 113:3108-3115.
55. Chagpar A.B., McMasters K.M., Scoggins C.R., Martin R.C., Thoene C., Edwards M.J. The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg 2008, 195:793-798.
56. Komenaka I.K., Martinez M.E., Pennington R.E., Hsu C.H., Clare S.E., Thompson P.A., et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 2010, 102:1178-1187.
57. Fyles A.W., McCready D.R., Manchul L.A., Trudeau M.E., Merante P., Pintilie M., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004, 351:963-970.
58. Hughes K.S., Schnaper L.A., Berry D., Cirrincione C., McCormick B., Shank B., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004, 351:971-977. CALGB and ECOG.
59. Whelan T.J., Pignol J.P., Levine M.N., Julian J.A., MacKenzie R., Parpia S., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
60. Hershman D.L., Wang X., McBride R., Jacobson J.S., Grann V.R., Neugut A.I. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 2006, 65:1353-1360.
61. Froud P.J., Mates D., Jackson J.S., Phillips N., Andersen S., Jackson S.M., et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 2000, 46:363-372.
62. Standards for Cancer Registries, Volume II, Data Standards and Data Dictionary, 13th ed.
63. April 2008, North American Association of Central Cancer Registries. Available at: Accessed October 12, 2011. http://www.naaccr.org/StandardsandRegistryOperations/VolumeII.aspx.
64. Cancer Trends Progress Report-2009/2010 Update, National Cancer Institute, NIH, DHHS, Bethesda, MD, April 2010. Available at: Accessed October 12, 2011. http://progressreport.cancer.gov.